AU2003289947A8 - Identification of pain-regulated gene in the dorsal root ganglion (drg) after cfa-induced arthritis - Google Patents

Identification of pain-regulated gene in the dorsal root ganglion (drg) after cfa-induced arthritis

Info

Publication number
AU2003289947A8
AU2003289947A8 AU2003289947A AU2003289947A AU2003289947A8 AU 2003289947 A8 AU2003289947 A8 AU 2003289947A8 AU 2003289947 A AU2003289947 A AU 2003289947A AU 2003289947 A AU2003289947 A AU 2003289947A AU 2003289947 A8 AU2003289947 A8 AU 2003289947A8
Authority
AU
Australia
Prior art keywords
drg
cfa
pain
identification
dorsal root
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003289947A
Other versions
AU2003289947A1 (en
Inventor
Annette Bieller
Eberhard Weihe
Martin K-H Schafer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal GmbH filed Critical Gruenenthal GmbH
Publication of AU2003289947A1 publication Critical patent/AU2003289947A1/en
Publication of AU2003289947A8 publication Critical patent/AU2003289947A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2003289947A 2003-02-05 2003-12-02 Identification of pain-regulated gene in the dorsal root ganglion (drg) after cfa-induced arthritis Abandoned AU2003289947A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10304680 2003-02-05
DE10304680.1 2003-02-05
PCT/EP2003/013597 WO2004070383A2 (en) 2003-02-05 2003-12-02 Identification of pain-regulated gene in the dorsal root ganglion (drg) after cfa-induced arthritis

Publications (2)

Publication Number Publication Date
AU2003289947A1 AU2003289947A1 (en) 2004-08-30
AU2003289947A8 true AU2003289947A8 (en) 2004-08-30

Family

ID=32841599

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003289947A Abandoned AU2003289947A1 (en) 2003-02-05 2003-12-02 Identification of pain-regulated gene in the dorsal root ganglion (drg) after cfa-induced arthritis

Country Status (2)

Country Link
AU (1) AU2003289947A1 (en)
WO (1) WO2004070383A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602006012840D1 (en) * 2006-09-22 2010-04-22 Visgeneer Inc Human protein phosphatase with EF-hands-1 (PPEF-1) - similar genvariant associated with T-cell lymphoblastic lymphoma
CN111620942B (en) * 2020-06-12 2021-10-15 中国科学院昆明动物研究所 Mature peptide of batus brucei leukotriene A4hydrolase inhibitor Motisin and application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668002A (en) * 1990-08-31 1997-09-16 The Wistar Institute DNA and polypeptide for tumor-associated antigen CO-029
US6274312B1 (en) * 1996-12-11 2001-08-14 Schering Corporation Intracellular regulatory molecules; related reagents
WO2000034470A1 (en) * 1998-12-10 2000-06-15 Song, Huaidong Npcbac06: human transitional endoplasmic reticulum atpase gene
EP1187924A1 (en) * 1999-06-03 2002-03-20 Cold Spring Harbor Laboratory Substrate trapping protein tyrosine phosphatases
DE10037759A1 (en) * 2000-08-03 2002-07-04 Gruenenthal Gmbh screening process
US20040254136A1 (en) * 2001-07-03 2004-12-16 Troy Carol M. Antisense oligonucleotides and related methods for regulating cell death
JP2005502335A (en) * 2001-08-08 2005-01-27 インサイト・ゲノミックス・インコーポレイテッド Cell growth, differentiation and cell death related proteins

Also Published As

Publication number Publication date
AU2003289947A1 (en) 2004-08-30
WO2004070383A2 (en) 2004-08-19
WO2004070383A3 (en) 2005-03-03

Similar Documents

Publication Publication Date Title
GB2396490B (en) Card connector
TW555250U (en) Card connector
ZA200906125B (en) Xylanases nucleic acids encoding them and methods for making and using them
IL181200A0 (en) Natural extract containing xanthohumol, and method for the production thereof and products produced therefrom
EP1676160A4 (en) Electro-optical circuitry having integrated connector and methods for the production thereof
IL184076A0 (en) Membrane card and method for the production and use thereof
AU2003261191A8 (en) Methods for producing biopolymers
GB0210325D0 (en) Secure data delivery
IL169318A0 (en) Pyrimidines, methods for the production thereof, and use thereof
AU2003289947A8 (en) Identification of pain-regulated gene in the dorsal root ganglion (drg) after cfa-induced arthritis
GB0207067D0 (en) Improved card game
GB2391720B (en) Card socket
GB2408425B (en) Data delivery
EP1644476A4 (en) Novel phytase and gene
AU2003297833A8 (en) Canine rankl and methods for preparing and using the same
GB0321797D0 (en) Extraction
EP1664308A4 (en) Nucleotide sequences and polypeptides encoded thereby useful for increasing plant size and increasing the number and size of leaves
GB0229967D0 (en) Protein production
EP1534531A4 (en) Product authentication
AU2003253818A8 (en) Card game
TW568366U (en) Improved antenna structure of CF card
TW585249U (en) High altitude popper
GB0328889D0 (en) Matching process
TW560737U (en) Card alignment structure of card type socket
GB0216534D0 (en) Extraction process

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase